Jonathan Violin Viridian Therapeutics, Inc.\De (VRDN) insider trading activity

Jonathan Violin is Chief Executive Officer of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 430,905 shares of VRDN, which is worth approximately $10.5 Million. The most recent transaction as insider was on Feb 02, 2023, when has been sold 50,000 shares (Common Stock) at a price of $36.8 per share, resulting in proceeds of $1,839,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 431K

0% 3M change

0% 12M change

Total Value Held $10.5 Million

Jonathan Violin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 02 2023	SELL Open market or private sale	$1,839,999 $36.8 p/Share	50,000 Reduced 10.4%	430,905 Common Stock
Jun 01 2022	SELL Open market or private sale	$366,000 $12.2 p/Share	30,000 Reduced 5.87%	480,905 Common Stock
May 02 2022	SELL Open market or private sale	$391,200 $13.04 p/Share	30,000 Reduced 5.55%	510,905 Common Stock
Apr 04 2022	SELL Open market or private sale	$68,148 $18.93 p/Share	3,600 Reduced 0.66%	540,905 Common Stock
Apr 01 2022	SELL Open market or private sale	$499,488 $18.92 p/Share	26,400 Reduced 4.62%	544,505 Common Stock
Mar 02 2022	SELL Open market or private sale	$192,800 $17.36 p/Share	11,106 Reduced 1.91%	570,905 Common Stock
Mar 01 2022	SELL Open market or private sale	$336,691 $17.82 p/Share	18,894 Reduced 3.14%	582,011 Common Stock
Feb 03 2022	SELL Open market or private sale	$17,416 $19.16 p/Share	909 Reduced 0.15%	600,905 Common Stock
Feb 02 2022	SELL Open market or private sale	$227,920 $18.47 p/Share	12,340 Reduced 2.01%	601,814 Common Stock
Feb 01 2022	SELL Open market or private sale	$327,482 $19.55 p/Share	16,751 Reduced 2.66%	614,154 Common Stock
Dec 08 2021	BUY Conversion of derivative security	-	627,564 Added 49.87%	630,905 Common Stock
Oct 27 2020	BUY Other acquisition or disposition	-	50,124 Added 50.0%	50,124 Common Stock

Also insider at

MGTA

Magenta Therapeutics, Inc. Healthcare

ATXS

Astria Therapeutics, Inc. Healthcare

Director

Jonathan Violin

Chief Executive Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRDN shares.

Notify only if

Value

Insider Trading

Get notified when an Viridian Therapeutics, Inc.\De insider buys or sells VRDN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Viridian Therapeutics, Inc.\DE

Track Activities on VRDN

Account